Bosentan
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Bosentan and local guidelines before prescribing.
Endothelin antagonist
Mechanism
Endothelin receptor antagonist.
Uses
Pulmonary arterial hypertension, digital ulcers in systemic sclerosis.
Dosing
- Bosentan Eisenmenger (adult) | 62.5 mg twice daily for 4 weeks, then 125 mg twice daily. Monthly LFTs; teratogenic - effective contraception needed.
Cardiology: Congenital heart disease
Side effects
Hepatotoxicity, anaemia, oedema, teratogenicity.
Interactions
Ciclosporin and glibenclamide; reduces hormonal contraception effect.
Contraindications and cautions
Pregnancy, liver disease
Monitoring
LFT, Hb, pregnancy test
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Contraindicated in moderate to severe hepatic impairment
Overdose and reversal
Supportive
Special advice
Monthly LFT; pregnancy tests monthly.
More from the textbook: uses, cautions and other points
- Endothelin pathway - endothelin receptor antagonists (bosentan, ambrisentan, macitentan) - teratogenic (effective contraception and monthly pregnancy tests), liver toxicity (monthly LFTs with bosentan), anaemia, oedema.
Respiratory: Anatomy, Physiology and Pharmacology - Endothelin receptor antagonists - ambrisentan, bosentan, macitentan. They are teratogenic , and bosentan needs LFT monitoring.
Respiratory: Pulmonary Vascular Disease - Endothelin receptor antagonists (ambrisentan, bosentan, macitentan) | PAH (specialist); teratogenic - pregnancy prevention; bosentan needs LFT monitoring; anaemia, oedema.
Respiratory: Pulmonary Vascular Disease - Keep warm (gloves), stop smoking, avoid triggers; nifedipine (modified-release) if needed; specialist referral for secondary cases or digital ulcers (iloprost, sildenafil, bosentan).
Surgery: Vascular surgery - Advanced pulmonary vasodilators: E.g. bosentan (an endothelin receptor antagonist), sildenafil.
Cardiology: Congenital heart disease - Sildenafil / bosentan / epoprostenol | Pulmonary arterial hypertension (specialist); no nitrates with sildenafil; bosentan - liver, teratogenic.
Respiratory: Anatomy, Physiology and Pharmacology - Specialist - sildenafil (PDE5 inhibitor), IV iloprost (severe attacks or ulcers), bosentan (prevents new digital ulcers in systemic sclerosis), botulinum toxin, sympathectomy.
Rheumatology: Connective tissue diseases - Pulmonary arterial hypertension - endothelin receptor antagonists (bosentan, ambrisentan, macitentan), PDE5 inhibitors (sildenafil, tadalafil), riociguat, prostacyclin analogues (iloprost, epoprostenol, selexipag); oxygen, diuretics, anticoagulation in some (see the Respiratory chapters).
Rheumatology: Connective tissue diseases
Where it is discussed in the book
- Cardiology: Congenital heart disease (2 mentions)
- Respiratory: Anatomy, Physiology and Pharmacology (2 mentions)
- Respiratory: Pulmonary Vascular Disease (2 mentions)
- Respiratory: Sleep and Breathing (Complete) (1 mention)
- Rheumatology: Connective tissue diseases (3 mentions)
- Surgery: Vascular surgery (1 mention)
- Integrated cardiology chapter (2 mentions)
- Integrated respiratory chapter (2 mentions)